Journal for ImmunoTherapy of Cancer

CCL5-armed oncolytic virus augments CCR5-engineered NK cell infiltration and antitumor efficiency
Feng Li, Yuqiao Sheng, Weizhou Hou, Padma Sampath, Daniel Byrd, Stephen Thorne, Yi Zhang

Journal for ImmunoTherapy of Cancer Feb 2020, 8 (1) e000131; DOI: 10.1136/jitc-2019-000131
FcγRII (CD32) modulates antibody clearance in NOD SCID mice leading to impaired antibody-mediated tumor cell deletion
Robert J Oldham, C Ian Mockridge, Sonya James, Patrick J Duriez, H T Claude Chan, Kerry L Cox, Vicentiu A Pitic, Martin J Glennie, Mark S Cragg

Journal for ImmunoTherapy of Cancer Jun 2020, 8 (1) e000619; DOI: 10.1136/jitc-2020-000619
Correction: Pre-existing inflammatory immune microenvironment predicts the clinical response of vulvar high-grade squamous intraepithelial lesions to therapeutic HPV16 vaccination
Journal for ImmunoTherapy of Cancer May 2020, 8 (1) e000563corr1; DOI: 10.1136/jitc-2020-000563corr1
Correction: Tumor microenvironment modulation enhances immunologic benefit of chemoradiotherapy
Journal for ImmunoTherapy of Cancer Mar 2020, 8 (1) e0485-9corr; DOI: 10.1136/jitc-2020-0485-9corr
Targeting the coding sequence: opposing roles in regulating classical and non-classical MHC class I molecules by miR-16 and miR-744
Michael Friedrich, Christoforos K Vaxevanis, Katharina Biehl, Anja Mueller, Barbara Seliger

Journal for ImmunoTherapy of Cancer Jun 2020, 8 (1) e000396; DOI: 10.1136/jitc-2019-000396
Mucosal inflammation predicts response to systemic steroids in immune checkpoint inhibitor colitis
Meghan J Mooradian, Daniel Y Wang, Alexandra Coromilas, Melissa Lumish, Tianqi Chen, Anita Giobbie-Hurder, Douglas B. Johnson, Ryan J. Sullivan, Michael Dougan

Journal for ImmunoTherapy of Cancer May 2020, 8 (1) e000451; DOI: 10.1136/jitc-2019-000451
Lactoferrin-containing immunocomplex mediates antitumor effects by resetting tumor-associated macrophages to M1 phenotype
Hongliang Dong, Yueyao Yang, Chenhui Gao, Hehe Sun, Hongmin Wang, Chao Hong, Jun Wang, Fangyuan Gong, Xiaoming Gao

Journal for ImmunoTherapy of Cancer Mar 2020, 8 (1) e000339; DOI: 10.1136/jitc-2019-000339
High dose-rate brachytherapy of localized prostate cancer converts tumors from cold to hot
Simon P Keam, Heloise Halse, Thu Nguyen, Minyu Wang, Nicolas Van Kooten Losio, Catherine Mitchell, Franco Caramia, David J Byrne, Sue Haupt, Georgina Ryland, Phillip K Darcy, Shahneen Sandhu, Piers Blombery, Ygal Haupt, Scott G Williams, Paul J Neeson

Journal for ImmunoTherapy of Cancer Jun 2020, 8 (1) e000792; DOI: 10.1136/jitc-2020-000792
Optimized combinatorial pMHC class II multimer labeling for precision immune monitoring of tumor-specific CD4 T cells in patients
Georg Alexander Rockinger, Philippe Guillaume, Amélie Cachot, Margaux Saillard, Daniel E Speiser, Georges Coukos, Alexandre Harari, Pedro J Romero, Julien Schmidt, Camilla Jandus

Journal for ImmunoTherapy of Cancer May 2020, 8 (1) e000435; DOI: 10.1136/jitc-2019-000435
EpCAM-high liver cancer stem cells resist natural killer cell–mediated cytotoxicity by upregulating CEACAM1
Dong Jun Park, Pil Soo Sung, Jung-Hee Kim, Gil Won Lee, Jeong Won Jang, Eun Sun Jung, Si Hyun Bae, Jong Young Choi, Seung Kew Yoon

Journal for ImmunoTherapy of Cancer Mar 2020, 8 (1) e000301; DOI: 10.1136/jitc-2019-000301

Main menu

Journal for ImmunoTherapy of Cancer

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

Journal for ImmunoTherapy of Cancer

Pages